BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37958563)

  • 1. CD40 Ligand-CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Dillemans L; Siddiquei M; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G; Struyf S
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proprotein convertase furin is a driver and potential therapeutic target in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
    Clin Exp Ophthalmol; 2022 Aug; 50(6):632-652. PubMed ID: 35322530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):32. PubMed ID: 34293080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; De Zutter A; Siddiquei MM; Blanter M; Allegaert E; Gikandi PW; De Hertogh G; Van Damme J; Opdenakker G; Struyf S
    Front Immunol; 2020; 11():601639. PubMed ID: 33552057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 studies in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G
    Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation.
    Abu El-Asrar AM; Ahmad A; Nawaz MI; Siddiquei MM; De Zutter A; Vanbrabant L; Gikandi PW; Opdenakker G; Struyf S
    Front Physiol; 2021; 12():807747. PubMed ID: 35082694
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of HMGB1 with oxidative stress markers and regulators in PDR.
    Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
    Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Opdenakker G
    Curr Eye Res; 2016 Dec; 41(12):1590-1600. PubMed ID: 27261371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Allegaert E; Siddiquei MM; Ahmad A; Gikandi P; De Hertogh G; Opdenakker G
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Ahmad A; Siddiquei MM; De Zutter A; Allegaert E; Gikandi PW; De Hertogh G; Van Damme J; Opdenakker G; Struyf S
    Front Immunol; 2019; 10():2752. PubMed ID: 31866994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
    Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.
    Rutella S; Vetrano S; Correale C; Graziani C; Sturm A; Spinelli A; De Cristofaro R; Repici A; Malesci A; Danese S
    J Cell Mol Med; 2011 Mar; 15(3):625-34. PubMed ID: 20158572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of PCED1B-AS1 in proliferative diabetic retinopathy and its involvement in retinal vascular endothelial cell proliferation.
    Wang X; Chen W; Lao W; Chen Y
    BMC Ophthalmol; 2022 Nov; 22(1):450. PubMed ID: 36418980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
    Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
    Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
    [No Abstract]   [Full Text] [Related]  

  • 18. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
    Usui-Ouchi A; Ouchi Y; Ebihara N
    Int Immunopharmacol; 2017 Nov; 52():70-76. PubMed ID: 28866026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.